Literature DB >> 6605407

Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens.

E S Groves, A Singer.   

Abstract

The present study has utilized cytotoxic T lymphocyte (CTL) responses specific for minor histocompatibility (minor H) antigens as an experimental approach to determining whether recognition of self MHC determinants is involved in the induction of T cell tolerance to self antigens. It was observed that C3H.SW splenic T cells from C3H.SW leads to B10 X B10.BR radiation bone marrow chimeras contained CTL precursors (pCTL) reactive against self C3H minor H antigens + H-2k but were tolerant to self C3H minor H antigens + H-2b. Precursor CTL with the reciprocal reactivity pattern were observed for C3H leads to B10 X B10.BR chimeras. In addition, it was observed that C3H.SW thymocytes from C3H.SW leads to B10 X B10.BR chimeras could generate minor H-specific CTL responses and were reactive against self C3H minor H antigens + H-2k, but were tolerant to self C3H minor H antigens + H-2b. Thus, the present study demonstrates that for peripheral and intrathymic T cell populations at least a component of T cell tolerance to self antigens is restricted by products of the MHC.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605407      PMCID: PMC2187151          DOI: 10.1084/jem.158.5.1483

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS.

Authors:  R D Owen
Journal:  Science       Date:  1945-10-19       Impact factor: 47.728

2.  T-cell inhibition of humoral responsiveness. II. Theory on the role of restrictive recognition in immune regulation.

Authors:  M Cohn; R Epstein
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

3.  Cellular and genetic control of antibody responses in vitro. I. Cellular requirements for the generation of genetically controlled primary IgM responses to soluble antigens.

Authors:  R J Hodes; A Singer
Journal:  Eur J Immunol       Date:  1977-12       Impact factor: 5.532

4.  Is self tolerance H-2 restricted?

Authors:  P Matzinger; J D Waterfield
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

5.  The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice.

Authors:  A M Kruisbeek; S O Sharrow; B J Mathieson; A Singer
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

7.  Antigen-presenting cells from nonresponder strain 2 guinea pigs are fully competent to present bovine insulin B chain to responder strain 13 T cells. Evidence against a determinant selection model and in favor of a clonal deletion model of immune response gene function.

Authors:  G A Dos Reis; E M Shevach
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

8.  Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells.

Authors:  A Singer; K S Hathcock; R J Hodes
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

9.  Cytotoxic T lymphocyte responses by chimeric thymocytes. Self-recognition is determined early in T cell development.

Authors:  A M Kruisbeek; R J Hodes; A Singer
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

10.  Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.

Authors:  J A Keene; J Forman
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  19 in total

1.  The inability of thyroid allografts to induce self-tolerance of organ-specific antigens in foetal lambs.

Authors:  P McCullagh
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

2.  Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells.

Authors:  Camillo Ricordi; Suzanne T Ildstad; Thomas E Starzl
Journal:  Transplant Sci       Date:  1992-04

Review 3.  Recognition of multiple class II signals by murine T cell antigen receptors. Speculation regarding the relationships among autoreactive, antigen-specific and alloreactive T cells.

Authors:  B W Needleman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 4.  Induction of MHC-restricted specificity and tolerance in the thymus.

Authors:  D Lo; Y Ron; J Sprent
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 5.  T cell repertoire and autoimmune diseases.

Authors:  L Imberti; A Sottini; D Primi
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Single-residue changes in class I major histocompatibility complex molecules stimulate responses to self peptides.

Authors:  A G Grandea; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Evidence that major histocompatibility complex restriction of foreign transplantation antigens occurs when tolerance is induced in neonatal mice and rats.

Authors:  L Desquenne-Clark; H Kimura; W K Silvers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Direct evidence for functional self-protein/Ia-molecule complexes in vivo.

Authors:  R G Lorenz; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.

Authors:  R Obst; N Netuschil; K Klopfer; S Stevanović; H G Rammensee
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  On the nature of peptides involved in T cell alloreactivity.

Authors:  O Rötzschke; K Falk; S Faath; H G Rammensee
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.